The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Amosova N.A.

FGBU "Gosudarstvennyĭ nauchnyĭ tsentr Rossiĭskoĭ Federatsii - Federal'nyĭ meditsinskiĭ biofizicheskiĭ tsentr im. A.I. Burnaziana" FMBA, Moskva

Smolentseva I.G.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia;
Tsentr ékstrapiramidnykh zabolevaniĭ, Moskva

Маslyuk О.А.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

Pavlov Iu.V.

Fakul'tetskaia khirurgicheskaia klinika im. N.N. Burdenko Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Gavrilov E.L.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

An analysis of causes of death in patients with Parkinson’s disease

Authors:

Amosova N.A., Smolentseva I.G., Маslyuk О.А., Pavlov Iu.V., Gavrilov E.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2): 70‑72

DOI: 10.17116/jnevro20171176270-72

Views: 26569

Downloaded: 344

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Amosova NA, Smolentseva IG, Маslyuk ОА, Pavlov IuV, Gavrilov EL. An analysis of causes of death in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2):70‑72. (In Russ.)
https://doi.org/10.17116/jnevro20171176270-72

 
МСФ на ЯМ
Close metadata
Recommended articles:
Criteria of syndrome frailty in Parkinson´s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):52-56
Causes of hospital mortality in adults based on medi­cal certificates of death. Russian Journal of Preventive Medi­cine. 2024;(3):7-13
Mortality from cere­brovascular diseases in the Russian Fede­ration before and during the COVID-19 epidemy: regional differences. Russian Journal of Preventive Medi­cine. 2024;(4):12-17
Tremor-dominant form of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):28-35
Nocturia in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):48-54
Asso­ciations of serum neuromarkers with clinical features of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):145-152
Problems in orga­nizing neurosurgical care for patients with Parkinson’s disease in the Russian Fede­ration. Burdenko's Journal of Neurosurgery. 2024;(3):5-13
The asso­ciation of single-nucleotide poly­morphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):82-88
Care algo­rithm for patients with chro­nic heart failure. Five steps to success. Russian Cardiology Bulletin. 2024;(3):6-15
Sarcopenia as a non-motor symptom of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):15-22

Objective. To determine population mortality rate and reasons of death in Parkinson’s disease (PD). Material and methods. To analyze reasons of death, medical death certificates and postmortem records as well as official results of the Federal state statistics service were used. According to the register of Parkinson’s disease (PD) patients during 2009—2012, the total mortality was 9.9%. The average age of patients died from the disease was 74.3 ± 2.4 years. The main reasons of death were PD (36.2%), circulatory illnesses (27.6%), respiratory diseases (12.1%), malignant neoplastic diseases (12.1%), other reasons (12.0%). Direct reasons of death in patients with PD were the complications of underlying disease in connection with the development of immobility and comorbidities. Timely correction of complications and comorbidities is a main strategy to extend life expectancy in patients with PD.

Keywords:

Parkinson’s disease
reasons of death
registry

Authors:

Amosova N.A.

FGBU "Gosudarstvennyĭ nauchnyĭ tsentr Rossiĭskoĭ Federatsii - Federal'nyĭ meditsinskiĭ biofizicheskiĭ tsentr im. A.I. Burnaziana" FMBA, Moskva

Smolentseva I.G.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia;
Tsentr ékstrapiramidnykh zabolevaniĭ, Moskva

Маslyuk О.А.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

Pavlov Iu.V.

Fakul'tetskaia khirurgicheskaia klinika im. N.N. Burdenko Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Gavrilov E.L.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

List of references:

  1. Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-427. https://doi.org/10.1212/WNL.17.5.427
  2. Shaw KM, Lees AJ, Stern GM. The impact of treatment with levodopa on Parkinson’s disease. Quarterly Journal of Medicine. 1980;49(3):283-293. https://doi.org/10.1093/oxfordjournals.qjmed.a067623
  3. Clarke CE. Mortality from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;68(2):254-255. https://doi.org/10.1136/jnnp.68.2.254
  4. Curtis L, Lees A, Stern G, Marmot M. Effect of L-Dopa on course of Parkinson’s disease. The Lancet. 1984;324(8396):211-212. https://doi.org/10.1016/S0140-6736(84)90493-8
  5. Marttila R, Rinne U, Siirtola T, Sonninen V. Mortality of patients with parkinson’s disease treated with levodopa. Journal of Neurology. 1977;216(3):147-153. https://doi.org/10.1007/BF00313615
  6. Levin OS. Fenomenologia i lechenie decompensazii bolezni Parkinsona. Nevrologicheskiy Jurnal. 2007;1:8-15. (In Russ.).
  7. Shtok VN. Ekstrapiramidnye rasstroistva. Rukovodstvo po diagnostike i lecheniyu. In: V.N. Shtok, I.A. Ivanova-Smolenskaya, O.S. Levin, eds. M.: MEDpress-inform; 2002. (In Russ.).
  8. Fahn S. Parkinson’s disease: 10 years of progress, 1997—2007. Mov Disord. 2010;25(1):2-14. https://doi.org/10.1002/mds.22796
  9. Guttman M, Slaughter P, Theriault M, DeBoer D, Naylor C. Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study. Neurology. 2001;57(12):2278-2282. https://doi.org/10.1212/WNL.57.12.2278
  10. Hely M, Morris J, Reid W, Trafficante R. Sydney multicenter study of Parkinson’s disease: Non-L-dopa-responsive problems dominate at 15 years. Movement Disorders. 2005;20(2):190-199. https://doi.org/10.1002/mds.20324
  11. Herlofson K, Lie S, Arsland D, Larsen J. Mortality and Parkinson disease: A community based study. Neurology. 2004;62(6):937-942. https://doi.org/10.1212/01.wnl.0000115116.56955.50
  12. Muller J, Wenning G, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study. Neurology. 2000;55(6):888-891. https://doi.org/10.1212/WNL.55.6.888
  13. Morgan J, Currie L, Harrison M, Bennett J, Trugman J, Wooten G. Mortality in Levodopa-Treated Parkinson’s Disease. Parkinson’s Disease. 2014:1-8. https://doi.org/2014/426976
  14. Louis E, Marder K, Cote L, Tang M, Mayeux R. Mortality From Parkinson Disease. Archives of Neurology. 1997;54(3):260-264. https://doi.org/10.1001/archneur.1997.00550150024011
  15. Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Are demented patients with Parkinson’s disease accurately reflected in prevalence surveys? A survival analysis. Neurology. 1991;41(8): 1240-1240. https://doi.org/10.1212/WNL.41.8.1240
  16. Levy G, Tang MX, Louis ED et al. The association of incident dementia with mortality in PD. Neurology. 2002;59(11):1708-1713. https://doi.org/10.1212/01.WNL.0000036610.36834.E0
  17. De Lau L, Breteler M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525-535. https://doi.org/10.1016/S1474-4422(06)70471-9
  18. D Lau L, Schipper C, Hofman A, Koudstaal P, Breteler M. Prognosis of Parkinson’s Disease. Arch Neurol. 2005;62(8):1265. https://doi.org/10.1001/archneur.62.8.1265
  19. Hughes T, Ross H, Mindham R, Spokes E. Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurologica Scandinavica. 2004;110(2):118-123. https://doi.org/10.1111/j.1600-0404.2004.00292.x
  20. Diem-Zangerl A, Seppi K, Wenning G, Trinka E, Ransmayr G, Oberaigner W, Poewe W. Mortality in Parkinson’s disease: A 20-year follow-up study. Movement Disorders. 2009;24(6):819-825. https://doi.org/10.1002/mds.22414
  21. Rajput AH, Uitti RJ, Rajput A, Offord KP. Mortality in Parkinson’s disease. Mov Disord. 2010;25:507-508. https://doi.org/10.1002/mds.22914

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.